Please assess the completion status of the following clinical trial:

Trial Title: A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with acne vulgaris and at least 20 but no more than 40 inflammatory lesions, 25-70 non-inflammatory lesions, no more than 2 nodules on the face~* Baseline IGA score of mild, moderate or severe~* Women of child-bearing potential must agree to use an effective method of birth control during the study and for 30 days after their final study visit~Exclusion Criteria:~* Any dermatologic condition or other medical problem that could interfere with clinical evaluation or requires the use of topical or systemic therapy that make evaluations and lesion count inconclusive~* Female subjects who are pregnant, nursing, or considering becoming pregnant~* Methemoglobin \> 2% at baseline~* Clinically significant anemia at baseline~* Use of topical or systemic medications to treat acne~* Use of medications that make acne worse, associated with methemoglobinemia, or nitric oxide donors

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- NVN1000 1% Gel (Type: EXPERIMENTAL): NVN1000 1% Gel twice daily
- NVN1000 4% Gel (Type: EXPERIMENTAL): NVN1000 4% Gel twice daily
- Vehicle Gel (Type: PLACEBO_COMPARATOR): Vehicle Gel twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).